Pharmacodynamics of long-acting folic acid-receptor targeted ritonavir-boosted atazanavir nanoformulations.

MLA

Puligujja, Pavan, et al. “Pharmacodynamics of Long-Acting Folic Acid-Receptor Targeted Ritonavir-Boosted Atazanavir Nanoformulations.” Biomaterials, vol. 41, Feb. 2015, pp. 141–50. EBSCOhost, https://doi.org/10.1016/j.biomaterials.2014.11.012.

APA

Puligujja, P., Balkundi, S. S., Kendrick, L. M., Baldridge, H. M., Hilaire, J. R., Bade, A. N., Dash, P. K., Zhang, G., Poluektova, L. Y., Gorantla, S., Liu, X.-M., Ying, T., Feng, Y., Wang, Y., Dimitrov, D. S., McMillan, J. M., & Gendelman, H. E. (2015). Pharmacodynamics of long-acting folic acid-receptor targeted ritonavir-boosted atazanavir nanoformulations. Biomaterials, 41, 141–150. https://doi.org/10.1016/j.biomaterials.2014.11.012

Chicago

Puligujja, Pavan, Shantanu S Balkundi, Lindsey M Kendrick, Hannah M Baldridge, James R Hilaire, Aditya N Bade, Prasanta K Dash, et al. 2015. “Pharmacodynamics of Long-Acting Folic Acid-Receptor Targeted Ritonavir-Boosted Atazanavir Nanoformulations.” Biomaterials 41 (February): 141–50. doi:10.1016/j.biomaterials.2014.11.012.